Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes?
暂无分享,去创建一个
[1] L. Jensen,et al. A vancomycin-resistant Enterococcus faecium isolate from a Danish healthy volunteer, detected 7 years after the ban of avoparcin, is possibly related to pig isolates. , 2004, The Journal of antimicrobial chemotherapy.
[2] Y. Agersø,et al. Detection of tet(M), tet(O) and tet(S) in tetracycline/minocycline-resistant Streptococcus pyogenes bacteraemia isolates. , 2003, The Journal of antimicrobial chemotherapy.
[3] P. Mullany,et al. Prevalence of Tetracycline Resistance Genes in Oral Bacteria , 2003, Antimicrobial Agents and Chemotherapy.
[4] B. Aracil,et al. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain. , 2003, The Journal of antimicrobial chemotherapy.
[5] J. Picazo,et al. Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia. , 2002, The Journal of antimicrobial chemotherapy.
[6] J. Picazo,et al. Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin. , 2002, The Journal of antimicrobial chemotherapy.
[7] F. Baquero,et al. Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain , 2002, Journal of Clinical Microbiology.
[8] R. Leclercq,et al. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. , 2002, The Journal of antimicrobial chemotherapy.
[9] H. J. Kolmos,et al. Beta-hemolytic Streptococcal Bacteremia: A Review of 241 Cases , 2002, Scandinavian journal of infectious diseases.
[10] M. Melbye,et al. Does Cross-sex Transmission Increase the Severity of Polio Infection? A Study of Multiple Family Cases , 2002, Scandinavian journal of infectious diseases.
[11] Pan‐Chyr Yang,et al. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan. , 2002, Microbial drug resistance.
[12] F. Baquero,et al. Antimicrobial Susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenesIsolates and Their Ecological Relationships: Results of a 1-Year (1998–1999) Multicenter Surveillance Study in Spain , 2001, Antimicrobial Agents and Chemotherapy.
[13] O. Cars,et al. Variation in antibiotic use in the European Union , 2001, The Lancet.
[14] K. Seme,et al. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. , 2001, The Journal of antimicrobial chemotherapy.
[15] M. Gourdeau,et al. Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada. , 2001, The Journal of antimicrobial chemotherapy.
[16] A. Efstratiou,et al. Unusual Occurrence of M Type 77, Antibiotic-Resistant Group A Streptococci in Southern Sweden , 2001, Journal of Clinical Microbiology.
[17] F. Aarestrup,et al. Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark. , 2000, Diagnostic microbiology and infectious disease.
[18] G. Volpe,et al. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD. , 2000, Microbial drug resistance.
[19] M. Zucca,et al. Macrolide resistance in group A streptococci. , 2000, The Journal of antimicrobial chemotherapy.
[20] J. Picazo,et al. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study. , 1999, Diagnostic microbiology and infectious disease.
[21] J. Marimón,et al. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. , 1999, Emerging infectious diseases.
[22] J. Melo-Cristino,et al. Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens. , 1999, Microbial drug resistance.
[23] P Huovinen,et al. Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. , 1998, The Journal of infectious diseases.
[24] P Huovinen,et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. , 1997, The New England journal of medicine.
[25] J. Embden,et al. TRANSFERABLE DRUG RESISTANCE TO GROUP A AND GROUP B STREPTOCOCCI , 1978, The Lancet.
[26] M. T. Foster,et al. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. , 1968, The New England journal of medicine.